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Abstract
Background: Pseudomonas aeruginosa causes lung infections in patients suffering from the genetic disorder Cystic
Fibrosis (CF). Once a chronic lung infection is established, P. aeruginosa cannot be eradicated by antibiotic
treatment. Phage therapy is an alternative to treat these chronic P. aeruginosa infections. However, little is known
about the factors which influence phage infection of P. aeruginosa under infection conditions and suitable broad
host range phages.
Results: We isolated and characterized a phage, named JG024, which infects a broad range of clinical and
environmental P. aeruginosa strains. Sequencing of the phage genome revealed that the phage JG024 is highly
related to the ubiquitous and conserved PB1-like phages. The receptor of phage JG024 was determined as
lipopolysaccharide. We used an artificial sputum medium to study phage infection under conditions similar to a
chronic lung infection. Alginate production was identified as a factor reducing phage infectivity.
Conclusions: Phage JG024 is a suitable broad host range phage which could be used in phage therapy. Phage
infection experiments under simulated chronic lung infection conditions showed that alginate production reduces
phage infection efficiency.
Background
Pseudomonas aeruginosa i sw e l lk n o w na sa no p p o r t u -
nistic human pathogen characterized by a high intrinsic
antibiotic tolerance [1,2]. In humans, P. aeruginosa can
cause urinary tract, respiratory tract, and burn wound
infections [3-5]. Respiratory tract infections caused by
P. aeruginosa are dreaded in patients suffering from the
genetic disorder Cystic Fibrosis (CF) [2,6,7]. CF patients
exhibit an increased mucus production in the lung [8].
Bacteria like P. aeruginosa are able to colonize this
mucus and cause chronic infections, which cannot be
eradicated by antibiotic treatment [4]. Several hypothesis
exist explaining the observed high antibiotic tolerance of
P. aeruginosa in the CF-lung, which is caused by special
growth conditions. These include growth as biofilm-like
microcolonies, which have been shown to increase
antibiotic tolerance up to 1000-fold [9,10]. A couple of
in vitro model systems have been described to simulate
a CF lung infection caused by P. aeruginosa [11-13].
The artificial sputum medium is a complex medium
based on components measured in the CF sputum [12].
It mimics the CF-lung environment during infection
and causes typical P. aeruginosa phenotypes as mucoidy
and microcolony formation [12]. Since eradication of
chronic P. aeruginosa infections by antibiotics fails,
phage therapy is a possibility to treat bacterial infections.
Advantages over antibiotics are the specificity of phages
and that phages can be isolated and investigated rapidly
[14]. For this reason, several suitable P. aeruginosa
broad host range phages have been characterized. The
Pseudomonas infecting PB1-like phages are widespread
in nature and possess highly conserved genomes. Com-
parative genome analysis of five PB1-like (PB1, SN,
14-1, LMA2 and LBL3) phages was recently published
and is the first genome report for these phages [15].
PB1-like phages belong to the Myoviridae phage family
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bp. The genomes encode for 88 (LBL3) to 95 proteins
(LMA2) [15]. More than 42 phages have been reported
to be PB1-like. These results are mainly based on DNA
hybridization and morphological studies [15,16]. More
recently, PB1-like phages as phage 14-1 have been
reported as part of a well defined phage cocktail to treat
P. aeruginosa burn wound infections [17]. The applica-
tion of phages as a therapeutical agent requires an in
depth understanding of the phage biology [18]. More-
over, phages which multiply well under in vitro condi-
tions can fail to replicate during treatment in vivo [19].
Therefore, phages and especially the ability of the phage
to infect the host in vivo should be investigated carefully
prior to use. Here we describe the in depth characteriza-
t i o no fab r o a dh o s tr a n g eP B 1 - l i k ep h a g ew i t has l i g h t
prevalence to clinical isolates. We used an artificial spu-
tum medium to simulate the conditions in the CF lung
and investigated the ability of phage JG024 to infect P.
aeruginosa and multiply under these conditions.
Results and Discussion
Isolation and host range of phage JG024
Phages were isolated from sewage as described in Meth-
ods. We isolated 59 P. aeruginosa specific phages and
used an initial set of 5 different P. aeruginosa strains as
the laboratory strains PAO1, PA14 as well as three clini-
cal isolates (BT2, PACF15 and MH19, Table 1) to test
the host range. One phage, which was named JG024,
was able to conduct clear lysis on this set of bacterial
strains. To determine the host range of JG024 in more
detail, we used 19 clinical isolates from CF patients and
from urinary tract infections as well as a collection of
100 environmental strains (Table 1). JG024 is able to
infect 84% of all tested clinical isolates. Furthermore,
JG024 is even capable of infecting a P. aeruginosa mucA
mutant and the clinical isolate BT73, which both
showed the same mucoid phenotype. mucA mutants
produce large amounts of the exopolysaccharide alginate
and mutations in mucA are critical for the conversion of
non-mucoid to mucoid P. aeruginosa variants in the
lung of CF patients [20,21]. Additionally, we determined
t h eh o s tr a n g eo ft h ep h a g eJ G 0 2 4w i t hac o l l e c t i o no f
100 P. aeruginosa environmental strains isolated from
different rivers (Oker, Aller, Weser) in Lower Saxony,
Germany. The results showed that JG024 was able to
infect 50% of the strains. Interestingly, phage JG024
showed a clear lysis for only 45% of the 50 lysed envir-
onmental isolates but was able to conduct clear lysis on
68% of the 19 lysed clinical isolates.
Family affiliation of JG024
To determine family affiliation of phage JG024, we
determined the nature of the nucleic acids and the mor-
phology of the phage to assign the family by comparison
[22]. Nucleic acids were isolated as described in Meth-
ods and identified as dsDNA due to its sensitivity to
restriction endonucleases like SacII, which cut only
dsDNA. SacII produced distinct fragments of approxi-
mately 30 kb, 25 kb and 8 kb (data not shown). Compu-
tational analysis of the SacII restriction sites in the
sequenced genome (see below) revealed slightly different
Table 1 Strains and phages used in this study.
Bacterial strain or phage Phenotype or genotype Reference
PAO1 wild type [48]
PA14 wild type [49]
FRD1 mucoid CF isolate [34]
PAO1 ΔmucA PAO1 mucA::aacC1-gfp Gm
R Sabrina Thoma, this laboratory,
unpublished
PAO1 ΔpilA pilA inactivated by allelic displacement; tagged with
eGFP, Tc
R,G m
R
[50]
PAO1 ΔfliM fliM inactivated by allelic displacement; tagged with
eGFP, Tc
R,G m
R
[50]
PAO1 ΔalgC PAO1 algC ::aacC1-gfp Gm
R Julia Garbe, this laboratory,
unpublished
BT2, BT72, BT73, RN3, RN43, RN45, NN84 clinical CF isolates Medical Highschool Hannover,
Germany
PACF15, PACF21, PAKL1, PAKL4, PACF60, PACF61,
PACF62, PACF63
clinical CF isolate Gerd Döring, Tübingen, Germany
Nr. 18, 19, 26, 29 urinary tract infection isolate Michael Hogardt, München, Germany
Environmental strains Katherina Selezska, HZI Braunschweig,
Germany
JG024 wild type PAO1 LPS specific lytic bacteriophage this study
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Page 2 of 10fragment sizes of 28,348 kb and 21,719 kb, respectively
as well as two fragments with a size of 8,49 kb and
7.718 kb, which we observed as one 8 kb fragment.
Electron microscopy (Figure 1) shows an icosahedral
head with a length of 80 nm and a width of 75 nm. The
contractile tail, which consists of a neck, a contractile
sheath and a central tube has a length of approximately
130 nm. Due to these morphological results and in
accordance with the presence of dsDNA, the phage
JG024 is grouped to the family Myoviridae. This family
is a member of the order Caudovirales which contains
exclusively tailed phages also from the families Siphovir-
idae and Podoviridae.
Receptor of phage JG024
We used different P. aeruginosa mutants to identify the
receptor of phage JG024 as outlined by others [23]. Afla-
gella mutant (ΔfliM), a pili mutant (ΔpilA)a n da nL P S
mutant (ΔalgC) were infected with the phage JG024. After
incubation, lysis was investigated on bacterial lawns (data
not shown). JG024 lyses the pili- and the flagella mutant
but not the P. aeruginosa ΔalgC mutant. The algC gene
encodes an enzyme with phosphoglucomutase and phos-
phomannomutase activity. A P. aeruginosa ΔalgC mutant
produces a truncated LPS core and lacks common antigen
suggesting that these structures might constitute the host
receptor for JG024 attachment [24,25].
Growth characteristics
To investigate growth parameters like the latent phase
a n dt h eb u r s ts i z eo ft h ep h a g eJ G 0 2 4 ,w ep e r f o r m e d
single step growth curves as described in Methods,
Figure 2. Phage JG024 has an estimated latent phase of
50 min. The burst size, which describes the mean num-
ber of phages liberated per bacterial cell was determined
as 180 phages per infected cell.
JG024 is a PB1-like phage
Phage JG024 DNA was sequenced and assembled at
McGill University as described in Methods. The genome
size of phage JG024 is 66,275 bp and has a GC content of
55.62%. Genome comparison using the blastx tool
revealed that phage JG024 is highly related to the wide-
spread and conserved PB1-like viruses [15,26]. It was
recently reported that these phages show a high sequence
similarity and limited horizontal gene transfer [15]. The
general characteristics as well as the similarity to phage
JG024 are shown in Table 2. The overall nucleotide simi-
larity to PB1-like phages varies between 86% to phage
PB1 and 95% to the phages SN and 14-1 (Table 2). We
also compared the JG024 genome sequence with PB1 and
SN using Mauve [27] and detected only few insertions or
deletions, Additional file 1 Figure S1. Due to the high
sequence similarity, the broad host range characteristic
as well as the morphology, we conclude that phage JG024
belongs to the PB1-like phages. In accordance with our
findings, PB1-like phages also have been shown to use
LPS as receptor [28]. Since the sampling location of
JG024 in Lower Saxony, Germany is different to all other
PB1-like phages, it underscores the broad environmental
distribution of this phage group probably due to the
broad host range [15].
Features of the JG024 genome
The schematic representation of the genome, with its
assumed ORFs, some functional assignments and overall
genetic organization is depicted in Figure 3. The gen-
ome of JG024 is compact organized with only 7.1%
Figure 1 Morphology of JG024. Electron microscopic image of
negatively stained JG024 phages, which exhibit a contractile tail
with a length of 130 nm. The icosahedral head of JG024 has a
length of 80 nm and a width of 75 nm.
Figure 2 Growth characteristics of JG024. One step growth curve
of phage JG024. A representative growth experiment of three
independent experiments is shown. The latent phase of JG024 takes
approximately 50 min and the phage is able to produce about 180
phage progeny per infected cell.
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found in the genome of JG024 using the program
RNAscan-SE 1.21 [29]. Interestingly, the GC content of
phage JG024 differs from its host (55.62% to 68%).
Comparison of the codon usage of JG024 with its host
P. aeruginosa showed that the phage shares the same
dominant codons for each amino acid except for valin,
serin and glutamate. To test if the genome of phage
JG024 is linear or circular, we used a method described
previously [30]. A linear genome of phage JG024 was
identified by treatment with exonuclease Bal31 which
degrades only double-stranded linear DNA from both
ends simultaneously (data not shown). However, we did
not identify the exact genome ends. This would indicate
that the genome of phage JG024 is circular permuted in
contradiction to the PB1 phages, which have been
reported to have non-permuted linear genomes [15].
Since the terminase protein of JG024 is highly (up to
99.6%) identical to that of the PB1 phages, we assume
phage JG024 to have a non-permuted linear genome.
Table 2 Comparison of the JG024 genome to the genomes of PB1-like phages 15.
Phage Genome size (bp) GC content (%) Predicted ORFs unique ORFs DNA identity (%) to JG024
JG024 66,275 55.62 94 1 100
PB1 65,764 55.5 93 - 86
F8 66,015 55.6 93 1 87
SN 66,390 55.6 92 2 95
14-1 66,238 55.6 90 - 95
LMA2 66,530 55.5 95 2 93
LBL3 64,427 55.5 88 2 92
Figure 3 Genome of JG024. Schematic representation of the JG024 genome with its assumed ORFs and some functional assignments. The
arrowheads point in the direction of transcription. Detected putative sigma70-promoters as well as potential terminator hairpin structures are
indicated. The complete genome is submitted with GenBank (NCBI, accession number: GU815091).
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comparative ORF prediction was possible. First, the
heuristic approach of GeneMark was used to identify
genes in small genomes under 100 kb [31]. With this
approach a total of 84 putative ORFs were identified. In
a second approach we used the NCBI ORF Finder pro-
gram coupled with the program blastp and compared
the translated proteins with the proteins of the PB1-like
phages [26,32]. Combination of the results of both
approaches revealed a total of 94 predicted ORFs as well
as one unique ORF in phage JG024.
No RNA polymerase was detected suggesting that this
phage uses the host transcriptional machinery, as it was
also suggested for the PB1-like family of phages.
We detected a putative structural gene cluster which
contains genes encoding for putative head structure pro-
teins (ORF 18 and 19) as well as for tail and baseplate
proteins (ORF 22-47). Moreover, ORF 40 was designated
as a lytic tail protein. It was shown for the phages 14-1
and LBL3 that this protein has a transglycosylase
domain with a N-acetyl-D-glucosamine binding site,
which shows a specific degradation of peptidoglycan
[15]. ORF 48 encodes a putative endolysin with a high
similarity to the endolysin of phage LMA2 (98.6%) and
belongs to a lysozyme-like superfamily. A putative holin
may be encoded by ORF 52, which shares a 100% iden-
tity to ORF 50 of phage F8 and to ORF 51 of phage 14-
1. It was suggested that these ORFs encode probable
holins since they are located near the endolysin gene
and they encode a small protein (201 aa) containing
three transmembrane domains [15].
Additionally, a complete DNA replication machinery
was detected suggesting that the DNA replication is
host independent as described for the PB1-like phages.
The respective gene cluster contains a DNA ligase (ORF
50), a helicase (ORF 55 and 56), a DNA polymerase III
(ORF 57 and 58), as well as a thymidylate synthase
(ORF 61). A putative primase was also found but is not
included in this gene cluster (ORF 77), as shown for the
other PB1-like phages [15]. Also, differences between
the PB1-like phages and JG024 were found. Phage 14-1
(ORF 71) and phage LBL3 (ORF 68) encode a hypotheti-
cal protein with a size of 434 aa. Interestingly, this pro-
tein is encoded by two ORFs in phage JG024 designated
ORF 72 (362 aa) and 73 (60 aa). The two ORFs are
separated by only 116 bp. Moreover, ORF 79 is a small
predicted gene with a size of 132 bp and encodes for a
unique protein in phage JG024. This ORF was identified
by two programs, GeneMark and ORF Finder, indepen-
dently. No functional indication could be pointed out
since there are no similarities to other proteins in the
databases and no conserved domains have been detected
in ORF 79. We also searched the genome of phage
JG024 for promoters, terminators and regulatory ele-
ments, see Methods. The PB1 phages do not contain a
phage RNA-polymerase and depend on the transcrip-
tional machinery of the host bacterium. Putative sigma
70-promoter regions have been predicted in PB1 phages
[15]. We detected two putative sigma 70-promoter
regions in the 5’-region of ORF 18 and ORF 22, similar
to the position of the putative promoters found in PB1
phages, see Table 3 and Figure 3[15]. In addition, we
also determined the location of six rho-independent
transcriptional terminators and checked if their position
is conserved to the other PB1 like phages, Table 3 and
Figure 3. Moreover, we searched for additional con-
served motifs in intergenic regions using MEME and
detected AT-rich boxes and additional conserved motifs
in intergenic regions. However, the function of the
motifs is unclear, their position indicates a possible
Table 3 Potential regulatory elements and intergenic motifs of the JG024 genome.
Position ORF Sequence Orientation Score dG (kcal mol
-1)
putative s70-dependent promoter elements:
9286..9336 ORF18 ATGTTTGAATCTCTTTTGAACGT TTGATGTTTCCCCTATAATAAGC GCACA Forward 1.22
13050..13100 ORF22 TCATCTATAAGTAACGTTATAAC ATAACGTCAATTTATATGCTCTA GACGT forward 1.19
putative rho-independent terminator elements:
2313..2343 ORF 10 AAGCCCGGAGCGATCCGGGCTTT TCTGTGTT reverse -17.5
16623..16644 ORF24 GGCCGGGTTTCCGGCCTTTGTT forward -12.3
35910..35942 ORF48 AAAAGGCCGCTTATTCAGCGGCC TTTTTGCTTT forward -18.3
35931..35900 ORF49 AAAAGGCCGCTGAATAAGCGGCC TTTTCTTTT reverse -18.3
59033..59059 ORF77 AGGCCGCCTTCGGGCGGTCTTTT CTTT forward -14.7
60667..60706 ORF80 AAAGCCCCGGACTCTAGTTCAGA ATCCGGGGCTTTCTTTT forward -23.8
60700..60657 ORF81 AAAGCCCCGGATTCTGAACTAGA GTCCGGGGCTTTGTCGCTTCT reverse -23.8
Position and orientation of putative sigma 70 promoters and putative rho-independent terminator regions. The putative promoters were identified using SAK and
Virtual Footprint as described in Methods. “Orf” indicates the Orf in the 3’-region of the putative promoter. Bold letters of the promoter sequences indicate -35
and -10 regions. The putative terminator regions were identified using the programs TransTerm and FindTerm as described in Methods. The indicated Orf is the
respective Orf in the 5’-region of the putative rho-independent terminator.
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factor as suggested earlier [15].
ASM infection assay
Since phage JG024 is able to infect 84% of the tested
clinical isolates in vitro we were interested if this phage
is able to infect P. aeruginosa under simulated CF lung
conditions. An artificial sputum medium (ASM) was
used to mimic the CF lung environment. Growth in
ASM leads to formation of typical biofilm-like microco-
lonies of P. aeruginosa and supports other phenotypic
changes observed under chronic infection conditions
[12]. At first, we tested the ability of phage JG024 to
lyse the non-mucoid wild type strain P. aeruginosa
PAO1 in ASM compared to LB medium. As described
in Methods, we monitored phage particles and noted an
increase of phage particles by a factor of nearly 500 000
in LB and in ASM by a factor of 10 000 (Figure 4). This
indicates cell lysis by phage JG024 under these non ideal
conditions (note that PAO1 was in stationary phase
prior to infection to allow comparison to ASM). When
we monitored infection of P. aeruginosa PAO1 in ASM
we noticed a 50-fold lower concentration of phage parti-
cles. This indicates a reduced efficiency of phage infec-
tion by JG024 under simulated chronic infection using
the artificial sputum medium. In parallel we tested a P.
aeruginosa CF-isolate, strain BT73, for susceptibility to
phage infection in LB and ASM. Unexpectedly, we
n o t i c e do n l ya1 . 9 - f o l dl o w e rp h a g en u m b e ri nA S M
compared to LB (Figure 4). We noticed that phage
JG024 was less effective against the CF isolate under
both conditions, since approximately tenfold less phage
particles were produced under both conditions
compared to PAO1. However, while strain BT73 is less
susceptible to phage lysis, the efficiency does not
decrease dramatically under ASM growth conditions.
In contrast to the P. aeruginosa PAO1 strain the CF-
isolate BT73 is mucoid and secretes the exopolysacchar-
ide alginate. We wondered if alginate overproduction
could explain the observed results. It was recently pub-
lished that even non-mucoid strains like the wild type
PAO1 express the exopolysaccharide alginate in
response to oxygen-limiting conditions [33]. We also
observed that cultures of PAO1 in ASM, which mimics
the CF lung, were highly viscous compared to the cul-
tures in LB medium, suggesting a high production of
alginate by the wild type PAO1 in this medium. If algi-
nate is the factor in our experimental setup which
decreases phage infection efficiency, a mucoid variant of
strain PAO1 should show a similar result as the clinical
isolate BT73. Therefore, we repeated the phage infection
experiments in LB and ASM with a P. aeruginosa mucA
mutant strain. We observed again only a 1.6-fold
decrease in ASM and an overall approximately tenfold
reduction in phage particles when compared with
P. aeruginosa PAO1 (Figure 4). These results are in
agreement with our hypothesis that alginate overproduc-
tion reduces phage infection efficiency. Moreover, they
point to alginate as the dominant factor for the decrease
in phage infection efficiency in ASM. To verify this
result, we performed the same experiment with P. aeru-
ginosa PAO1 in LB medium and increasing alginate
concentrations. We chose alginate concentrations of 50,
100, 200, 500 μg/ml up to 1000 μg/ml, since non-
mucoid P. aeruginosa strains have been reported to pro-
duce 50-200 μg/ml alginate, while mucoid isolates pro-
duce up to 1000 μg/ml alginate [34-36]. In accordance
with our hypothesis, the presence of alginate reduced
phage multiplication in our test assay. A concentration
of 50 to 200 μg/ml alginate resulted in an almost 20-
fold reduction of phage particles compared to LB med-
ium alone in accordance with the 50-fold reduction of
phage particles observed in ASM compared to LB. This
effect is even more obvious with alginate concentations
of 500 and 1000 μg/ml, where we observed a reduction
of phage particles by a factor of 130 and almost 2800,
respectively.
Conclusions
We could show that the phage JG024 belongs to the
PB1-like phages and shares several characteristic fea-
tures of this group. These phages are widespread in nat-
ure and very successful. A new member of this group,
phage JG024, was isolated and characterized. General
growth characteristics as well as the genome were inves-
tigated, showing that JG024 is able to pass one infection
cycle in approximately 50 min. Genome analysis
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Moreover, we could show that JG024 has broad spec-
trum activity with a prevalence to clinical isolates. Also,
infection of the host P. aeruginosa was even possible
under challenging conditions like the ASM medium
which mimics the CF lung. High viscosity and microcol-
ony growth of the host were only small obstacles for
JG024 to infect and multiply under these conditions.
These results show that this group of bacteria could be
an important contribution to phage therapy. Moreover,
we established a method to investigate the possibility of
a phage to lyse bacteria under infection conditions prior
to use for phage therapy in vivo.
Methods
Bacterial strains and growth conditions
Table 1 shows the genotype and phenotypes of the bac-
teria and phage JG024 used in this study. The 100 envir-
onmental Pseudomonas aeruginosa strains used in this
study origin from a comprehensive screen of approx.
400 environmental river strains. These were genetically
characterized using the ArrayTube hybridization chip
[37]. The 100 strains used here are all different in their
core genomic SNP pattern and were chosen such to
represent the entire population genetic diversity cur-
rently known for P. aeruginosa. Details of the compre-
hensive screen will be published elsewhere. P.
aeruginosa strains were routinely propagated in Luria
Bertani (LB) broth medium aerobically at 37°C. The
composition of the artificial sputum medium (ASM) is
described elsewhere [12].
Phage Isolation
Phages were isolated from sewage following a simple
enrichment procedure. Samples from a sewage plant
Steinhof in Braunschweig, Germany were centrifuged for
5 min at 4100 × g (Biofuge fresco). Ten ml of the super-
natant were mixed with 5 ml of a P. aeruginosa over-
night culture and incubated in 50 ml LB broth at room
temperature. After an incubation of 48 h, the cells were
sedimented by centrifugation at 4100 × g (Biofuge
fresco) for 10 min and the supernatant was transferred
to a clean tube. To kill remaining bacteria, several drops
of chloroform were added to the supernatant and the
emulsion was mixed for 30 s. To separate the phages,
appropriate dilutions of the phage lysate were spotted
onto bacterial lawns of top-agar plates. Top-agar plates
were produced by adding approximately 5*10
8 cells/ml
of P. aeruginosa from an overnight LB broth to 3.5 ml
of LB top-agar (0.75%). The inoculated top-agar was
overlaid on an LB agar plate and allowed to solidify.
After incubation at 37°C for 10 to 16 h zones of lysis
were monitored. Single plaques, derived from a single
phage, were separated by stinging with a pipette tip into
the plaque followed by resuspending the phages in SM
buffer (100 mM NaCl, 8 mM MgSO4, 50 mM Tris-HCl,
pH 7.5). The resulting phage lysate was stored at 4°C.
Electron microscopy
The morphology of the phages was detected by negative
staining with uranyl acetate and transmission electron
microscopy. Phages were allowed to absorbe onto a thin
carbon film, prepared on mica, from a liquid sample for
different time points, washed in TE buffer (10 mM
TRIS, 2 mM EDTA, pH 6.9) and distilled water. Phages
were negatively stained by floating the carbon film for
approx. 15 sec on a drop of 2% aqueous uranyl acetate.
Then, the carbon film was picked up with copper grids
(300 mesh), blotted semi-dry with filter paper and was
subsequently air dried. Samples were examined in a
Zeiss EM910 transmission electron microsope at an
acceleration voltage of 80 kV and at calibrated magnifi-
cations. Images were recorded digitally with a Slow-Scan
CCD-Camera (ProScan, 1024 × 1024, Scheuring,
Germany) with ITEM-Software (Olympus Soft Imaging
Solutions, Münster, Germany). Brightness and contrast
were adjusted with Adobe Photoshop CS3.
Phage host range spectrum and detection of host
receptor
To determine the phage host range, top-agar plates with
the potential host lawn were prepared. Top-agar plates
were produced by adding approximately 5*10
8 cells/ml
of P. aeruginosa from an overnight LB broth to 3.5 ml
of LB top agar (0.75%). Ten μl of a phage stock solution
were spotted on the top-agar plate and incubated at
37°C for 12 to 16 h. After incubation, the appearance of
the lysis zones at the site where the phage suspension
was added, was examined. Each phage was tested against
each bacterial strain in triplicate in independent experi-
ments. The lysis was categorized as clear (+), turbid (0)
and no reaction (-) as described [38]. For detection of
the phage receptor molecule, we used a P. aeruginosa
flagella mutant (ΔfliM), a pili mutant (ΔpilA)a n da n
LPS mutant (ΔalgC), which were infected with the
phage JG024 as described above. The strains for the
receptor identification are derived from a PAO1 wild-
type and therefore belong to the same serotype as
PAO1, namely serotype O5 [39]. An effect on the effi-
ciency of plating was not observed for the strains with
intact LPS.
Phage growth characteristics
To determine phage growth characteristics like burst
size and duration of the infection cycle, single step
growth experiments were performed as previously
described with some modifications [40,41]. P. aeruginosa
was grown aerobically in 10 ml LB medium until
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OD578 of 0.3, an aliquot containing 5*10
8 phages was
added to the culture which corresponds to a multiplicity
of infection (MOI) of 0.16. Therefore, it is likely that a
cell is infected by only one phage and that the amount
of infected bacteria is equal to the amount of the initial
phage concentration. After addition of the phages, one
aliquot was immediately used for determination of the
phage titer. Then, phages were allowed to adsorb for 15
min. Afterwards, cultures were diluted in LB 10
4-, 10
5-,
10
6-a n d1 0
7 -fold and incubated at 37°C for 60 min.
Samples for phage enumeration were taken aseptically
at different time points after infection. The burst size
was determined as: (phage titer at the end of the single
step growth curve at time point 55 min minus phage
titer at time point 20 min) divided by phage titer at
time point 20 min. The latent phase was estimated at
the midpoint of the exponential phase of a one step
growth experiment [40,41].
Sequencing, analysis and annotation of phage genomes
To isolate phage DNA, phages were propagated in top-
agar plates as described above. After growth at 37°C the
plates were overlayed with 10 ml SM buffer and incu-
bated with shaking at 4°C for 4 h. The supernatant was
sterile filtrated (0.22 μm) and stored at 4°C. Phage DNA
was isolated using the Qiagen Lambda Kit according to
manufacturer’s instructions. Ten ml phage lysate with a
titer of at least 1*10
10 phages/ml were used to isolate up
to 1 μg/μl pure phage DNA. Digestion with restriction
endonucleases was done following the protocols of the
manufacturer. Whole genome sequencing of the phage
JG024 was done at the McGill University and Génome
Québec Innovation Centre (Montréal, QC, Canada)
using the Genome Sequencer FLX and 454 Technology.
A total of 66,684 reads with an average length of 344
bases was assembled to one single contig with a 300-
fold coverage. The annotation of the unknown phage
genes was done by using the software GeneMark.HMM
[31]. The Heuristic approach of GeneMark was used to
identify genes in small genomes under 100 kb. The
identified genes were compared with the NCBI ORF
Finder [32]. Nucleotide sequences were scanned for
homologues using the Basic Alignment Search Tool
(blastx) [26]. To search for tRNA genes in the phage
sequences the internet tool tRNAscan-SE 1.21 was used
[29]. Sequence comparison was conducted using Clus-
talW2 online analysis tool [42]. Investigation of the
codon usage was performed using a software tool based
on JCat [43]. The genome sequence as well as the anno-
tation is deposited with the GenBank (National Center
for Biotechnology Information) using the following
accession number: GU815091.
Identification of promoter regions, terminator structures
and other motifs
The genome of phage JG024 was scanned for the pre-
sence of sigma 70-dependent promoter regions using
t h ew e bs e r v i c eS A K[ 4 4 ] .P u t a t i v ep r o m o t e rr e g i o n s
w i t has c o r ea b o v e1w e r es c a n n e df o rt h ep r e s e n c eo f
conserved -10 and -35 regions using the Virtual Foot-
print software [45]. Two promoter regions were identi-
fied in this way. Rho-independent terminator structures
were identified using the TransTerm [46] and FindTerm
(Softberry, Inc.) software tools. The program MEME
was used for identification of conserved intergenic
motifs in phage JG024 [47].
ASM infection assay
Phage susceptibility of P. aeruginosa in ASM medium
was tested in 24 well plates. 1 ml ASM medium and as
control LB medium were inoculated with indicated
strains aerobically for 24 h at 37°C. An OD 578 of 0.5
was used for the inoculation. Afterwards, 1*10
5 phages
were added which describes the initial phage concentra-
tion. After incubation for additional 24 h at 37°C the
colony forming units (CFU) as well as the plaque form-
ing units (PFU) were determined. To determine the
change in phage concentration we divided the final
phage concentration after 24 h by the initial phage con-
centration. To determine the effect of alginate the same
experiment was performed in LB with purified alginate
using increasing concentrations in a range of 50 μg/ml
to 1 mg/ml. Alginate was purified from mucoid P. aeru-
ginosa strain FRD1 [34] as described previously [36].
Additional material
Additional file 1: Supplementary Figure S1. Graph and schematic
representation of a Mauve comparison using phage JG024, phage PB1
and SN.
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